Evidence map›Paper›PMID 39314806›Full record

ArticleInfectious medicine2024

Characterization of isoniazid resistance and genetic mutations in isoniazid-resistant and rifampicin-susceptible

Dongxin Liu, Bing Zhao, Yang Zheng, Xichao Ou, Shengfen Wang, Yang Zhou, Yuanyuan Song, Hui Xia, Qiang Wei, YanLin Zhao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Prevalence and resistance spectrum ofMicrobiology spectrum · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dongxin LiuNational Pathogen Resource Center, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Bing ZhaoNational Tuberculosis Reference Laboratory, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Yang ZhengNational Tuberculosis Reference Laboratory, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Xichao OuNational Tuberculosis Reference Laboratory, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Shengfen WangNational Tuberculosis Reference Laboratory, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Yang ZhouNational Tuberculosis Reference Laboratory, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Yuanyuan SongNational Tuberculosis Reference Laboratory, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Hui XiaNational Tuberculosis Reference Laboratory, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Qiang WeiNational Pathogen Resource Center, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
YanLin ZhaoNational Tuberculosis Reference Laboratory, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with tuberculosis resistant to isoniazid but susceptible to rifampicin (H Methods: Results: Of the 4922 strains, 384 (7.8 %) were H Conclusion: Ser315Thr in

Indexed as

Mono-isoniazid resistanceMycobacterium tuberculosisResistance mutationWhole-genome sequencing

Identifiers

PMID39314806
PMCPMC11417578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.